The Rise and Fall of Insulin Secretion in Type 1 Diabetes Mellitus

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2006 Jan 13

PMID 16404554

Citations 44

Authors

E B Tsai

N A Sherry

J P Palmer

K C Herold

Affiliations

Soon will be listed here.

Abstract

An understanding of the natural history of beta cell responses is an essential prerequisite for interventional studies designed to prevent or treat type 1 diabetes. Here we review published data on changes in insulin responses in humans with type 1 diabetes. We also describe a new analysis of C-peptide responses in subjects who are at risk of type 1 diabetes and enrolled in the Diabetes Prevention Trial-1 (DPT-1). C-peptide responses to a mixed meal increase during childhood and through adolescence, but show no significant change during adult life; responses are lower in adults who progress to diabetes than in those who do not. The age-related increase in C-peptide responses may account for the higher levels of C-peptide observed in adults with newly diagnosed type 1 diabetes compared with those in children and adolescents. Based on these findings, we propose a revised model of the natural history of the disease, in which an age-related increase in functional beta cell responses before the onset of autoimmune beta cell damage is an important determinant of the clinical features of the disease.

Citing Articles

Leveraging continuous glucose monitoring for personalized modeling of insulin-regulated glucose metabolism.

Erdos B, ODonovan S, Adriaens M, Gijbels A, Trouwborst I, Jardon K Sci Rep. 2024; 14(1):8037.

PMID: 38580749 PMC: 11371931. DOI: 10.1038/s41598-024-58703-6.

Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).

Baidal D, Ballou C, Rickels M, Berney T, Pattou F, Payne E Diabetes Care. 2023; 46(4):697-703.

PMID: 36657975 PMC: 10148684. DOI: 10.2337/dc22-1155.

Immunological markers in type 1 diabetes mellitus in Thi-Qar province, southern Iraq.

Hamadi G J Med Life. 2022; 15(10):1234-1239.

PMID: 36420297 PMC: 9675295. DOI: 10.25122/jml-2021-0387.

Abnormal Expression of an Insulin Synthesizing Enzyme in Islets of Adult Autoantibody Positive Donors.

Teitelman G J Histochem Cytochem. 2022; 70(10):695-706.

PMID: 36341551 PMC: 9660365. DOI: 10.1369/00221554221138368.

Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening.

Sims E, Cuthbertson D, Felton J, Ismail H, Nathan B, Jacobsen L Diabetes Care. 2022; 45(12):2982-2990.

PMID: 36326757 PMC: 9763026. DOI: 10.2337/dc22-1362.

References

Bonner-Weir S . Islet growth and development in the adult. J Mol Endocrinol. 2000; 24(3):297-302. DOI: 10.1677/jme.0.0240297. View

Bonner-Weir S, Deery D, Leahy J, Weir G . Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes. 1989; 38(1):49-53. DOI: 10.2337/diab.38.1.49. View

Amiel S, Caprio S, Sherwin R, Plewe G, Haymond M, Tamborlane W . Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab. 1991; 72(2):277-82. DOI: 10.1210/jcem-72-2-277. View

Polonsky K, Given B, Hirsch L, Shapiro E, Tillil H, Beebe C . Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest. 1988; 81(2):435-41. PMC: 329588. DOI: 10.1172/JCI113338. View

. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002; 346(22):1685-91. DOI: 10.1056/NEJMoa012350. View

Ilic S, Jovanovic L, Wollitzer A . Is the paradoxical first trimester drop in insulin requirement due to an increase in C-peptide concentration in pregnant Type I diabetic women?. Diabetologia. 2000; 43(10):1329-30. DOI: 10.1007/s001250051530. View

Ludvigsson J, Heding L, LARSSON Y, Leander E . C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control. Acta Paediatr Scand. 1977; 66(2):177-84. DOI: 10.1111/j.1651-2227.1977.tb07830.x. View

Saad R, Keenan B, Danadian K, Lewy V, Arslanian S . Dihydrotestosterone treatment in adolescents with delayed puberty: does it explain insulin resistance of puberty?. J Clin Endocrinol Metab. 2001; 86(10):4881-6. DOI: 10.1210/jcem.86.10.7913. View

Brandou F, Brun J, Mercier J . Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab. 2004; 90(2):761-7. DOI: 10.1210/jc.2004-0329. View

10.

Sherry N, Tsai E, Herold K . Natural history of beta-cell function in type 1 diabetes. Diabetes. 2005; 54 Suppl 2:S32-9. DOI: 10.2337/diabetes.54.suppl_2.s32. View

11.

Bonner-Weir S, Baxter L, Schuppin G, Smith F . A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes. 1993; 42(12):1715-20. DOI: 10.2337/diab.42.12.1715. View

12.

Finegood D, Scaglia L, Bonner-Weir S . Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes. 1995; 44(3):249-56. DOI: 10.2337/diab.44.3.249. View

13.

Daneman D, Clarson C . Residual beta-cell function in children with type 1 diabetes: measurement and impact on glycemic control. Clin Invest Med. 1987; 10(5):484-7. View

14.

Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay I . UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet. 1997; 350(9087):1288-93. DOI: 10.1016/s0140-6736(97)03062-6. View

15.

Kim S, Abbasi F, Reaven G . Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care. 2004; 27(8):1998-2002. DOI: 10.2337/diacare.27.8.1998. View

16.

Bonner-Weir S . Perspective: Postnatal pancreatic beta cell growth. Endocrinology. 2000; 141(6):1926-9. DOI: 10.1210/endo.141.6.7567. View

17.

Polonsky K, Frank B, Pugh W, Addis A, Karrison T, Meier P . The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes. 1986; 35(4):379-86. DOI: 10.2337/diab.35.4.379. View

18.

Lohr M, Kloppel G . Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia. 1987; 30(10):757-62. DOI: 10.1007/BF00275740. View

19.

Moran A, Jacobs Jr D, Steinberger J, Hong C, Prineas R, Luepker R . Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999; 48(10):2039-44. DOI: 10.2337/diabetes.48.10.2039. View

20.

Clarson C, Daneman D, Drash A, Becker D, Ehrlich R . Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care. 1987; 10(1):33-8. DOI: 10.2337/diacare.10.1.33. View